Digital Pathology & Imaging - software & AI news

Daily news on software, AI, and companies shaping digital pathology & imaging.

Showing 302 results
MRI machine in a hospital imaging room with a patient and radiologist

Jul 9, 2026

AI-Powered Imaging Diagnostics Market to Reach US$ 9.73 Billion

The AI-powered imaging diagnostics market is projected to grow significantly, reaching an estimated US$9.73 billion by 2033, with a compound annual growth rate (CAGR) of 22.3% from 2025 to 2033. This growth reflects a shift from pilot projects to operational frameworks in hospitals, where AI technologies are increasingly utilized for urgent scan triage and improved diagnostic workflows across various imaging modalities.Recent developments highlight the rapid advancement of AI in imaging diagnost
Flat illustration of a CT scan machine

Jul 9, 2026

AI-Powered Imaging Diagnostics Market Set to Reach USD 9.73

The AI-powered imaging diagnostics market is projected to grow significantly, reaching USD 9.73 billion by 2033, driven largely by advancements in artificial intelligence across various imaging modalities.This market, which was valued at USD 1.97 billion in 2025, is expected to expand at a compound annual growth rate (CAGR) of 22.3% from 2026 to 2033. Key factors contributing to this growth include the rising demand for enhanced diagnostic accuracy and efficiency, as well as the integration of A
Silhouette of coronary plaque and cardiac CT scan

Jul 9, 2026

Caristo Diagnostics to Highlight New Findings Reinforcing the Science of Its Coronary Inflammation and Plaque Analysis Technologies at SCCT 2026

Caristo Diagnostics is set to showcase significant advancements in AI-driven cardiovascular technologies at the upcoming SCCT 2026 Annual Scientific Meeting. Notably, three abstracts nominated for the Young Investigator Award will feature findings from the University of Oxford's ORFAN registry, emphasizing the application of the FAI-Score in both contrast and non-contrast cardiac CT scans.The presentations will explore the enhanced ability of FAI-Score to quantify coronary inflammation, providin
ultrasound transducer and patient monitor silhouettes

Jul 8, 2026

GE HealthCare explores growth in medical imaging and diagnostics

GE HealthCare is strategically enhancing its presence in medical imaging, diagnostics, and patient monitoring, with a focus on providing integrated solutions for hospitals and health systems worldwide.As a prominent player in medical technology, GE HealthCare offers a wide array of imaging and diagnostic equipment designed to streamline clinical workflows and assist healthcare professionals in making informed decisions. The company’s technology is pivotal in various care settings, including radi
Minimalist illustration of a heart with plaque

Jul 8, 2026

Caristo Diagnostics to Highlight New Findings Reinforcing the Science of Its Coronary Inflammation and Plaque Analysis Technologies at SCCT 2026

Caristo Diagnostics is set to present significant advancements in its AI-driven coronary inflammation and plaque analysis technologies at the SCCT 2026 Annual Scientific Meeting.The upcoming conference will showcase findings from the University of Oxford-led ORFAN registry, where three out of six nominated abstracts for the SCCT Young Investigator Award utilize Caristo's technologies. Notably, this includes the application of the Fat Attenuation Index (FAI) Score on non-contrast cardiac CT for t
A patient undergoing a cardiac CT scan in a clinical setting.

Jul 7, 2026

Catalyst MedTech Announces Channel Partnership with APQ

Catalyst MedTech has announced a strategic partnership with APQ Health to enhance access to advanced cardiac CT angiography (CCTA) visualization and plaque analysis services. This collaboration aims to address the growing demand for early detection and personalized risk assessment in coronary artery disease management.The partnership comes at a time when healthcare providers are increasingly adopting cardiac CT as a primary diagnostic tool for chest pain. However, many face challenges such as li
A bottle of ultrasound gel and probe in a clinical setting

Jul 7, 2026

AI in Ultrasound Imaging Market to Reach $2.23 Billion by 2030 with Growing Demand for Point-of-Care Diagnostics

The AI in ultrasound imaging market is on a significant growth trajectory, projected to increase from $1.28 billion in 2025 to $2.23 billion by 2030, reflecting a compound annual growth rate of 11.8%. This expansion is largely fueled by the rising demand for point-of-care diagnostics, advancements in machine learning, and the increasing incidence of cancer, which necessitates improved diagnostic capabilities for better patient outcomes.Key players in the industry, such as Siemens Healthineers an
A minimalist representation of clinical data analysis with an upward arrow.

Jul 6, 2026

Praise Ifenna Okwuba on the Future of AI-Powered Diagnostics in Healthcare

Praise Ifenna Okwuba, a data scientist at the forefront of AI in healthcare, highlights the transformative potential of AI-powered diagnostics in enhancing diagnostic accuracy and patient care.Okwuba points out that as artificial intelligence gains traction in healthcare, machine learning and advanced analytics are emerging as critical tools to tackle persistent challenges in the sector. He emphasizes that AI's ability to process vast amounts of clinical data can lead to significant improvements
A minimalist representation of a newborn brain monitor with brain wave patterns.

Jul 6, 2026

Neurobell Raises $5.5 Million To Expand AI-Powered Newborn Brain Monitor

NeuroBell, an Irish medtech firm, has successfully secured $5.5 million in funding to facilitate the U.S. launch of its innovative AI-driven brain monitoring device for newborns, known as LUNA, while also eyeing expansion into European markets.The funding round, spearheaded by Elkstone, saw contributions from Parkview Health and other existing investors. Parkview's involvement is particularly noteworthy as it builds on a clinical partnership aimed at enhancing the device's adoption across U.S. h
A lung nodule model on a clinical table with a CT scanner in the background.

Jul 3, 2026

Median Technologies’ eyonis LCS obtains CE marking

Median Technologies has achieved a significant milestone with the CE marking of its eyonis LCS, a Class IIb medical device, under the new European Medical Device Regulation (MDR 2017/745). This certification, awarded by GMED, attests to the device's compliance with stringent European standards regarding patient safety and clinical effectiveness, enabling its commercialization across the European Economic Area.eyonis LCS leverages artificial intelligence and machine learning to assist clinicians
Cardiac diagnostic device in a clinical setting

Jun 30, 2026

Pro Medicus (ASX:PME) AI Partnership Keeps Healthcare Software Stock In Focus

Pro Medicus (ASX:PME) has garnered significant market attention following its recent AI partnership with Echo IQ (ASX:EIQ), which aims to enhance its medical imaging capabilities.This collaboration marks a strategic move for Pro Medicus, allowing it to integrate third-party cardiac diagnostic software into its existing Visage platform. The partnership involves an initial investment of A$10 million, with the potential for an additional A$10 million based on regulatory milestones. This investment
Flat illustration of an EEG device for neonatal monitoring

Jun 29, 2026

Cork medtech NeuroBell bags $5.5m for its AI neonatal monitor

Cork-based medtech company NeuroBell has successfully secured $5.5 million in funding to advance its AI-driven neonatal monitor, Luna, targeting US market entry this year.The funding round was led by Elkstone and included contributions from several entities, such as Parkview Health and Enterprise Ireland. Luna is designed to identify seizures in newborns, a critical capability given that these events often lack visible symptoms, making early detection vital to prevent potential long-term brain d